For instance, CD19 is highly expressed in B cell malignancies [such as B cell lymphoma and acute lymphoblastic leukemia (ALL)] as well as in autoimmune disorders characterized by aberrant B cell activity, including systemic lupus erythematosus (SLE) and RA. Here, CD19 is linked to systemic lupus erythematosus.